According to Zhitong Finance App, Meinong Biotech (301156.SZ) announced that the company's shareholder Shanghai Quanyu Zhihe Management Consulting Firm (limited partnership) (hereinafter referred to as “Quanyu”) is the concerted actor of Hong Wei, the company's employee shareholding platform and controlling shareholder and actual controller. Due to the financial requirements of some partners, it is planned to reduce its holdings of the company's shares by no more than 1.4078 million shares within 3 months from the date of disclosure of this announcement (that is, no more than 1% of the company's share capital).